Amsterdam, the Netherlands – Cancer Biomarkers, published by IOS Press (now part of Sage), is pleased to announce that from January 1, 2024 (Volume 39, Issue 1) onwards the journal has transitioned to a Gold Open Access publication. This means that all articles published after that date are immediately and permanently openly available online for readers to view, download, share, and reuse. This enables authors to more easily comply with funder and institutional mandates.
“When Cancer Biomarkers began publication in 2005, our primary goal was to expand the scientific and clinical knowledge on this then emerging means to detect, diagnose, and treat cancer,” explained Editor-in-Chief Sudhir Srivastava, PhD, MPH. “The field continues to evolve supporting the advancement of precision oncology. We are extremely happy to advance to the next stage in the journal’s own evolution: migration to a fully open access publication model.”
Cancer Biomarkers is now recognized as one of the most influential journals in the world devoted exclusively to the field. The transition to fully open content will increase the journal’s impact and benefit the entire cancer research community, including authors, readers, libraries, hospitals, funding agencies – and ultimately patients and their families.
Cancer Biomarkers offers a rigorous peer-review process and operates with rapid manuscript processing times. Accepted papers are now published Open Access under a Creative Commons CC BY-NC 4.0 license, and authors retain copyright to their published work. The move to Open Access does not impact the editorial process, and the Editorial Office retains its independent right to accept or decline submitted papers based on their merit and quality.
A competitive introductory Open Access Fee, also known as an Article Processing Charge (APC), has been set at US$1500 / €1500 for a CC-BY NC 4.0 license. There is also an option to select the CC BY 4.0 license for US$2150 / €2150, which is required by certain funders. These fees are valid until September 1, 2024. After that date, the fee will be US$2800 / €2800 for a CC BY NC 4.0 license. CC BY 4.0 licenses may be granted upon request. Fees will not apply to certain publication types like editorials and letters. Fees may be waived under certain circumstances, particularly for authors from low-income countries as defined by Research4Life.
Now that IOS Press is part of Sage, If an author’s institution has an Open Access agreement with Sage, then some or all of the APC may be paid by the author’s institution according to the terms of their agreement.
Instructions for manuscript submission can be found here.
CONTACT For additional information, contact Gabriela Ricci, IOS Press (g.ricci@iospress.nl).
